4.86
+7.05%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Rxsight
From its filings with the US Securities and Exchange Commission
Rxsight is based in Aliso Viejo, California and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker RXST. The SEC classifies its business as ophthalmic goods. In the fiscal year to 31 December 2025, it reported revenue of $134.5m and a net loss of $38.9m. At that date it held total assets of $311.8m and shareholders' equity of $275.7m. By business, LAL brought in 80.4% of revenue, followed by L D D at 15.4% and Service Warranty, Service Contracts, And Accessories at 4.3%.
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing high-quality customized vision to patients following cataract surgery. Our proprietary RxSight® Light Adjustable Lens system (“RxSight system”) is the first and only commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system is comprised of our RxSight Light Adjustable Lens®(LAL®/LAL+®, collectively the “LAL”), RxSight Light Delivery Device (“LDD”) and related accessories. The LAL is a premium intraocular lens (“IOL”) made from the proprietary silicone-based photosensitive material that undergoes controlled changes in refractive power when exposed to specific ultraviolet (“UV”) light patterns generated by the LDD.
We designed our RxSight system to address limitations of conventional premium IOL technologies by providing doctors with a more precise and adaptable method for achieving desired visual outcomes for their patients. Conventional premium IOLs require patients to select their visual priorities before surgery and accept the optical trade-offs inherent in those choices. Surgeons must rely on a series of preoperative measurements and predictive formulae to determine the appropriate lens power. If the selected power is not optimal, the patient may experience less-than-ideal results that could require a subsequent corneal refractive procedure or other corrective measures to achieve intended vision targets.
Quoted from its 10-K, filed 25 Feb 2026. Read the filing on SEC.gov ↗
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 30 Jul 2021
- Employees
- 461
- Website
- rxsight.com ↗
- Head office
- 100 COLUMBIA STREET, ALISO VIEJO, CA, 92656
- Incorporated in
- DE
- Classification
- Ophthalmic Goods
- Filer status
- Accelerated filer
Leadership
Pay as last reported
- Mr. J. Andy CorleyIndependent Chairman of the Board$262,445
- Dr. Ron KurtzPresident, Chief Executive Officer, Director, since 2016$7.0m
- Dr. Ilya GoldshlegerCo-President, Chief Operating Officer$5.8m
- Mr. Eric WeinbergCo-President, Chief Business Development Officer$5.8m
- Mr. Mark WilterdingChief Financial Officer
- Mr. Scott GainesChief Customer Officer
- Ms. Julie AndrewsIndependent Director$219,945
- Ms. Juliet BakkerIndependent Director$214,945
- Mr. Raymond CohenIndependent Director
- Dr. Tamara FountainIndependent Director$209,945
- Dr. William LinkIndependent Director$201,195
- Ms. Shweta ManiarIndependent Director$204,945
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 24
- Environment
- 23
- Social
- 22
- Governance
- 27
- Carbon reduction policy
- No
- Human rights policy
- No
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Rxsight Inc has several notable strengths:
Weaknesses
- Rxsight Inc also faces some weaknesses:
Opportunities
- Rxsight Inc can capitalize on the following opportunities:
Threats
- Rxsight Inc should be aware of the following threats:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.